Latest:
Dr. Wenham on the Importance of Clinical Trials in Ovarian Cancer
Robert Wenham, MD, MS, FACOG, FACS, discusses the importance of clinical trials in ovarian cancer.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Robert Montal, MD
Latest:
Dr. Montal on Molecular Predictors of Recurrence With Adjuvant Sorafenib in HCC
Robert Montal, MD, visiting researcher, Icahn School of Medicine, Mount Sinai Hospital, discusses biomarker findings of the phase III STORM trial, which explored adjuvant treatment with sorafenib (Nexavar) in patients with hepatocellular carcinoma (HCC).
Robert R. Kuske, MD
Latest:
Dr. Kuske on APBI Via Multicatheter Interstitial Brachytherapy
Robert R. Kuske, MD, radiation oncologist, Arizona Breast Cancer Specialists, discusses the analysis of the Pooled Registry of Multicatheter Interstitial Sites Experience, which examined the safety of accelerated partial breast irradiation via multicatheter interstitial brachytherapy.
Robert Rowley, MD
Latest:
Navigating the EHR Marketplace How to Choose the Right EHR for Your Oncology Practice
Navigating the EHR marketplace can be dizzying, with numerous products available to choose from, including locally installed client/server systems that require server hardware, local networks, data backup, and IT support, as well as hosted, Web-based systems.
Robert Svatek, MD, MSCI
Latest:
New Methods of Boosting Response to Bladder Cancer Immunotherapy Explored
Although bacillus Calmette-Guérin (BCG) therapy has significantly improved outcomes for patients with non–muscle invasive bladder cancer since its introduction nearly 40 years ago, there is a pressing need to enhance responses to BCG and to distinguish which patients would respond to treatment early on in the course of therapy.
Robert Wechsler-Reya, PhD
Latest:
Models Pave the Way for Improved Outcomes in Medulloblastoma
To discover targeted therapies for the more common and severe types of medulloblastoma, a laboratory at Sanford Burnham Prebys Medical Discovery Institute has led efforts to develop genetically engineered mouse models and patient-derived xenografts for studying the molecular basis of the disease.
Robert Wong, MD
Latest:
Dr. Wong on Risk Factors for Hepatitis B-Associated HCC
Robert Wong, MD, MS, assistant clinical professor of medicine, director of research and education, Division of Gastroenterology and Hepatology at Alameda Health System, Highland Hospital, discusses the risk factors of hepatitis B-associated hepatocellular carcinoma (HCC).